Global Information
회사소개 | 문의 | 비교리스트

세계의 방사성의약품 시장 규모 조사 : 방사성동위원소별, 공급원별, 용도별, 최종사용자별 및 지역별 예측

Global Radiopharmaceuticals Market Size study, by Radioisotope, by Source, by Application, by End-User and Regional Forecasts 2019-2026

리서치사 Bizwit Research & Consulting LLP
발행일 2019년 05월 상품 코드 871558
페이지 정보 영문
가격
US $ 4,950 ₩ 5,882,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,427,000 Printable PDF (Enterprise License)


세계의 방사성의약품 시장 규모 조사 : 방사성동위원소별, 공급원별, 용도별, 최종사용자별 및 지역별 예측 Global Radiopharmaceuticals Market Size study, by Radioisotope, by Source, by Application, by End-User and Regional Forecasts 2019-2026
발행일 : 2019년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 방사성의약품(Radiopharmaceuticals) 시장에 대해 조사했으며, 시장 성장 촉진요인·저해요인, 방사성동위원소·공급원·용도·최종사용자·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 주요 요약

  • 시장 현황
  • 주요 동향
  • 전체 및 부문별 시장 예측
    • 방사성동위원소별
    • 공급원별
    • 용도별
    • 최종사용자별
    • 지역별
  • 조사 방법
  • 조사 가정

제2장 방사성의약품 시장 정의와 범위

  • 연구 목적
  • 시장 정의와 범위
    • 산업 진화
    • 조사 범위
  • 조사 대상 기간
  • 환율

제3장 방사성의약품 시장 역학

  • See Saw 분석
    • 시장 성장 촉진요인
    • 시장 과제
    • 시장 기회

제4장 방사성의약품 시장 분석

  • Porter's Five Forces 분석
    • 구매자의 협상력
    • 공급업체의 협상력
    • 신규 참여업체의 위협
    • 대용품의 위협
    • 업계내의 경쟁
    • Porter's Five Forces 분석에 대한 향후 접근
  • PEST 분석
    • 정치
    • 경제
    • 사회
    • 기술
  • 주요 구입 기준
  • 규제 체계
  • 투자/도입 시나리오
  • 애널리스트의 제안과 결론

제5장 방사성의약품 시장 : 방사성동위원소별

  • 시장 현황
  • 시장 실적 - 잠재적인 모델
  • 주요 시장 진출 기업
  • 방사성의약품 시장, 하위 부문 분석
    • 테크네튬 99
    • 갈륨 67
    • 요오드 123
    • 불소 18
    • 루비듐 82
    • 이트륨 90
    • 루테튬 177

제6장 방사성의약품 시장 : 공급원별

  • 시장 현황
  • 시장 실적 - 잠재적인 모델
  • 주요 시장 진출 기업
  • 방사성의약품 시장, 하위 부문 분석
    • 원자로
    • 사이클로트론

제7장 방사성의약품 시장 : 용도별

  • 시장 현황
  • 시장 실적 - 잠재적인 모델
  • 주요 시장 진출 기업
  • 방사성의약품 시장, 하위 부문 분석
    • 순환기
    • 소화기과
    • 종양학
    • 신장학
    • 신경학
    • 면역학
    • 기타

제8장 방사성의약품 시장 : 최종사용자별

  • 시장 현황
  • 시장 실적 - 잠재적인 모델
  • 주요 시장 진출 기업
  • 방사성의약품 시장, 하위 부문 분석
    • 병원
    • 외래 수술 센터
    • 진단 센터
    • 기타

제9장 지역 분석별 방사성의약품 시장

  • 방사성의약품 시장, 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 기타 유럽 지역
  • 아시아
    • 중국
    • 인도
    • 일본
    • 기타 아시아태평양 지역
  • 라틴아메리카
    • 브라질
    • 멕시코
  • 기타 세계 지역
    • 남미
    • 중동 및 아프리카

제10장 경쟁 상황

  • 기업의 시장 점유율(데이터 입수 가능성별)
  • 주요 시장 전략
  • 기업 개요
    • Advanced Accelerator Applications(AAA)
    • Bayer AG
    • Eckert & Ziegler
    • GE Healthcare
    • IBA Radiopharma Solutions
    • Lantheus Holdings Inc.
    • Mallinckrodt Plc
    • Nordion Inc.
    • Positron Corporation
    • Siemens Healthineers

제11장 조사 방법

  • 조사 방법
    • 데이터마이닝
    • 분석
    • 시장 예측
    • 검증
    • 출판
    • 조사 가정
KSM 19.07.10

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF RADIOPHARMACEUTICALS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF RADIOPHARMACEUTICALS MARKET
  • TABLE 3. RADIOPHARMACEUTICALS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY RADIOISOTOPE 2016-2026 (USD BILLION)
  • TABLE 8. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SOURCE 2016-2026 (USD BILLION)
  • TABLE 9. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY APPLICATION 2016-2026 (USD BILLION)
  • TABLE 10. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD BILLION)
  • TABLE 11. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. RADIOPHARMACEUTICALS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. RADIOPHARMACEUTICALS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 48. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. U.S. RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 52. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 53. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. CANADA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 58. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 61. UK RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 62. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 63. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 66. GERMANY RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 67. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 68. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 69. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 71. ROE RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 72. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 73. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 76. CHINA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 77. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 78. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 81. INDIA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 82. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 83. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 84. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 86. JAPAN RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 87. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 88. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 89. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 91. ROAPAC RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 92. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 93. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 94. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 96. BRAZIL RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 97. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 98. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 99. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 100. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 101. MEXICO RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 102. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 103. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 104. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 105. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 106. ROLA RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 107. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 108. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 109. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 110. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 111. ROW RADIOPHARMACEUTICALS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. RADIOPHARMACEUTICALS MARKET, RESEARCH METHODOLOGY
  • FIG 2. RADIOPHARMACEUTICALS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. RADIOPHARMACEUTICALS MARKET, KEY TRENDS 2017
  • FIG 5. RADIOPHARMACEUTICALS MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. RADIOPHARMACEUTICALS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. RADIOPHARMACEUTICALS MARKET, PEST ANALYSIS
  • FIG 8. RADIOPHARMACEUTICALS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 20. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 21. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 22. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 23. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 24. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 25. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 26. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 27. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 28. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 29. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 30. RADIOPHARMACEUTICALS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 31. RADIOPHARMACEUTICALS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
  • FIG 33. EUROPE RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
  • FIG 34. ASIA PACIFIC RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
  • FIG 35. LATIN AMERICA RADIOPHARMACEUTICALS MARKET 2016 & 2026 (USD BILLON)
  • FIG 36. RADIOPHARMACEUTICALS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)

Global Radiopharmaceuticals Market valued approximately USD 5.72 billion in 2018 is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2019-2026. The Radiopharmaceuticals Market is continuously growing in the global scenario at significant pace. Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. Increasing incidence of cardiovascular diseases, growing preference for PET and SPET scans, rise in consciousness about positive effects and enhancements in radiotracers are the substantial driving factors of the market during the forecast period. Moreover, increase in use of radiopharmaceuticals in neurological applications are the factors that likely to create numerous opportunity in the near future. However, scarcity of radioisotopes, strict regulatory standards and high cost of the procedure are the factors that limiting the growth of the market during the forecast period.

The regional analysis of Global Radiopharmaceuticals Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share due to presence of excellent research facilities and rising healthcare expenditure in the region. Europe is estimated to grow at stable growth rate in the global Radiopharmaceuticals market over the upcoming years. Further, Asia-Pacific is anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to rising demand for PET and SPECT devices and rising patient awareness levels pertaining to cardiovascular diseases and oncology in the region.

The major market player included in this report are:

  • Advanced Accelerator Applications (AAA)
  • Bayer AG
  • Eckert & Ziegler
  • GE Healthcare
  • IBA Radiopharma Solutions
  • Lantheus Holdings Inc.
  • Mallinckrodt Plc
  • Nordion Inc.
  • Positron Corporation
  • Siemens Healthineers

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Radioisotope:

  • Technetium-99
  • Gallium-67
  • Iodine-123
  • 18F
  • Rubidium-82
  • Yttrium-90
  • Lutetium-177
  • By Source:
  • Nuclear Reactors
  • Cyclotrons

By Application:

  • Cardiology
  • Gastroenterology
  • Oncology
  • Nephrology
  • Neurology
  • Immunology
  • Others

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers

    Diagnostic Centers

    Others

By Regions:

    North America

    U.S.

    Canada

    Europe

    UK

    Germany

    Asia Pacific

    China

    India

    Japan

    Latin America

    Brazil

    Mexico

    Rest of the World

Furthermore, years considered for the study are as follows:

    Historical year - 2016, 2017

    Base year - 2018

    Forecast period - 2019 to 2026

Target Audience of the Global Radiopharmaceuticals Market in Market Study:

    Key Consulting Companies & Advisors

    Large, medium-sized, and small enterprises

    Venture capitalists

    Value-Added Resellers (VARs)

    Third-party knowledge providers

    Investment bankers

    Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Radiopharmaceuticals Market, by Radioisotope, 2016-2026 (USD Billion)
    • 1.3.2. Radiopharmaceuticals Market, by Source, 2016-2026 (USD Billion)
    • 1.3.3. Radiopharmaceuticals Market, by Application, 2016-2026 (USD Billion)
    • 1.3.4. Radiopharmaceuticals Market, by End-User, 2016-2026 (USD Billion)
    • 1.3.5. Radiopharmaceuticals Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Radiopharmaceuticals Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Radiopharmaceuticals Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Radiopharmaceuticals Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria
  • 4.4. Regulatory Framework
  • 4.5. Investment Vs Adoption Scenario
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Radiopharmaceuticals Market, by Radioisotope

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Radiopharmaceuticals Market, Sub Segment Analysis
    • 5.4.1. Technetium-99
      • 5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.2. Gallium-67
      • 5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.3. Iodine-123
      • 5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.4. 18F
      • 5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.5. Rubidium-82
      • 5.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.6. Yttrium-90
      • 5.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.7. Lutetium-177
      • 5.4.7.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.7.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Radiopharmaceuticals Market, by Source

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Radiopharmaceuticals Market, Sub Segment Analysis
    • 6.4.1. Nuclear Reactors
      • 6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.2. Cyclotrons
      • 6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Radiopharmaceuticals Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Key Market Players
  • 7.4. Radiopharmaceuticals Market, Sub Segment Analysis
    • 7.4.1. Cardiology
      • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.2. Gastroenterology
      • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.3. Oncology
      • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.4. Nephrology
      • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.5. Neurology
      • 7.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.6. Immunology
      • 7.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.7. Others
      • 7.4.7.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.7.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Radiopharmaceuticals Market, by End-User

  • 8.1. Market Snapshot
  • 8.2. Market Performance - Potential Model
  • 8.3. Key Market Players
  • 8.4. Radiopharmaceuticals Market, Sub Segment Analysis
    • 8.4.1. Hospitals
      • 8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.2. Ambulatory Surgical Centers
      • 8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.3. Diagnostic Centers
      • 8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.4. Others
      • 8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9. Radiopharmaceuticals Market, by Regional Analysis

  • 9.1. Radiopharmaceuticals Market, Regional Market Snapshot (2016-2026)
  • 9.2. North America Radiopharmaceuticals Market Snapshot
    • 9.2.1. U.S.
      • 9.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.3. Sources breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.2.2. Canada
      • 9.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.2.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.3. Europe Radiopharmaceuticals Market Snapshot
    • 9.3.1. U.K.
      • 9.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.3.2. Germany
      • 9.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.3.3. Rest of Europe
      • 9.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.3.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.3.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.3.3.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.4. Asia Radiopharmaceuticals Market Snapshot
    • 9.4.1. China
      • 9.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.4.2. India
      • 9.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.4.3. Japan
      • 9.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.3.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.4.4. Rest of Asia Pacific
      • 9.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.4.4.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.5. Latin America Radiopharmaceuticals Market Snapshot
    • 9.5.1. Brazil
      • 9.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.5.2. Mexico
      • 9.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.5.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 9.6. Rest of The World
    • 9.6.1. South America
      • 9.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.1.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 9.6.2. Middle East and Africa
      • 9.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.2.2. Radioisotope breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.2.3. Source breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.2.4. Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 9.6.2.5. End-User breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 10. Competitive Intelligence

  • 10.1. Company Market Share (Subject to Data Availability)
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Advanced Accelerator Applications (AAA)
      • 10.3.1.1. Overview
      • 10.3.1.2. Financial (Subject to Data Availability)
      • 10.3.1.3. Summary
      • 10.3.1.4. Recent Developments
    • 10.3.2. Bayer AG
    • 10.3.3. Eckert & Ziegler
    • 10.3.4. GE Healthcare
    • 10.3.5. IBA Radiopharma Solutions
    • 10.3.6. Lantheus Holdings Inc.
    • 10.3.7. Mallinckrodt Plc
    • 10.3.8. Nordion Inc.
    • 10.3.9. Positron Corporation
    • 10.3.10. Siemens Healthineers

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
    • 11.1.6. Research Assumption
Back to Top
전화 문의
F A Q